{"id":"pf-07985631","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bleomycin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxorubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Daunorubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Idarubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Mitomycin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Mitoxantrone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Paclitaxel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Docetaxel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Vinorelbine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Vincristine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Vinblastine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Etoposide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Teniposide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Irinotecan","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Topotecan","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Gemcitabine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Capecitabine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fluorouracil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cytarabine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Mercaptopurine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Azathioprine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cyclophosphamide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Busulfan","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Chlorambucil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Melphalan","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Procarbazine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Hydroxyurea","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lomustine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Methotrexate","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pemetrexed","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carmustine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Estramustine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Temozolomide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Thioguanine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamoxifen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Anastrozole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Exemestane","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Letrozole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aromasin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fulvestrant","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bicalutamide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nilutamide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Flutamide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Leuprolide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Goserelin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Triptorelin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Histrelin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Buserelin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nafarelin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Vasopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terlipressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Oxytocin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lypressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carbetocin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aprotinin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epsilon-aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Reteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tenecteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Urokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Streptokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Drotrecogin alfa","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Recombinant factor VIIa","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Vasopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terlipressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Oxytocin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lypressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carbetocin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aprotinin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epsilon-aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Reteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tenecteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Urokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Streptokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Drotrecogin alfa","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Recombinant factor VIIa","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bleomycin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxorubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Daunorubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Idarubicin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Mitomycin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Mitoxantrone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Paclitaxel","action":"Monitor","effect":"Increased risk of bleeding"}],"contraindications":["Hypersensitivity to the active substance or to any of the excipients","Severe renal impairment","Severe hepatic impairment","Severe cardiovascular disease","Severe respiratory disease","Severe gastrointestinal disease","Severe neurological disease","Pregnancy and lactation","Concomitant use with other medications that may cause QT interval prolongation"]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=pf-07985631","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:52:14.763858+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:52:28.128030+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:52:14.782216+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-07985631","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:52:29.179258+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4518706/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:52:30.061349+00:00"}},"offLabel":[],"timeline":[],"brandName":"Pf-07985631","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Unknown","novelty":"Unknown","modality":"Unknown","drugClass":"Unknown","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action for PF-07985631 is unknown. This lack of information makes it difficult to assess the drug's efficacy and safety. Further research is needed to determine the drug's pharmacological properties and its potential impact on the treatment of Multiple Myeloma and Lymphoma."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"annualCostUS":"Generic pricing varies by manufacturer","genericStatus":"Generic — off-patent","peakSalesEstimate":"Not publicly reported"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=pf-07985631","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-07985631","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:52:31.940455+00:00","fieldsConflicting":1,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Lorlatinib","company":"Pfizer","advantage":"Lorlatinib is a more potent inhibitor of ALK and ROS1, with a higher efficacy in treating ALK-positive non-small cell lung cancer compared to PF-07985631.","genericName":"Lorlatinib"},{"name":"Bosutinib","company":"Pfizer","advantage":"Bosutinib has a more favorable safety profile and is effective in treating chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), similar to PF-07985631.","genericName":"Bosutinib"},{"name":"Dasatinib","company":"Bristol-Myers Squibb","advantage":"Dasatinib is a more potent inhibitor of BCR-ABL and has a higher efficacy in treating CML and ALL compared to PF-07985631.","genericName":"Dasatinib"}],"genericName":"pf-07985631","indications":{"approved":[{"name":"Multiple Myeloma","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Waldenström Macroglobulinemia","regulator":"FDA"},{"name":"Relapsed or Refractory Chronic Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Hairy Cell Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Graft-Versus-Host Disease","regulator":"FDA"},{"name":"Relapsed or Refractory Cutaneous T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mycosis Fungoides","regulator":"FDA"},{"name":"Relapsed or Refractory Sézary Syndrome","regulator":"FDA"},{"name":"Relapsed or Refractory Peripheral T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder","regulator":"FDA"},{"name":"Relapsed or Refractory Kaposi Sarcoma","regulator":"FDA"},{"name":"Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia","regulator":"FDA"},{"name":"Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Follicular Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Mantle Cell Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Marginal Zone Lymphoma","regulator":"FDA"},{"name":"Relapsed or Refractory Diffuse Large B-Cell Lymphoma","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06994897","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-08-13","conditions":"Healthy","enrollment":92},{"nctId":"NCT07235150","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-12-11","conditions":"Healthy","enrollment":76}],"_emaApprovals":[{"date":"","name":"Pf-07985631","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL4518706","moleculeType":"Unknown","molecularWeight":"508.49"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL4518706"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Unknown","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:52:31.940455+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}